« Stem Cell Politics |
| Beta-Amyloid: An Antibiotic? »
March 16, 2010
I was thinking the other day about the sheer number of reasonable chemical structures that have never been made. Chemical space is famously roomy - that's how we make a living in the drug industry, since we prefer to make things that have never been made before. And it still surprises non-chemists when I tell them that I make new compounds all the time - the feeling, I think, is that anything that's reasonably easy to make surely must have been mined out long ago. Not so. (It's worth remembering, though, that just because something's never been reported doesn't always mean that you can't buy it).
What brought this to mind was a steroid structure that I saw during a presentation. Looking at it like a medicinal chemist, I wondered idly if the carbons in the famous steroid backbone had ever been swapped out much with oxygen or nitrogen atoms. And in a few cases they have (more for oxygen, in some natural products), but for the most part, no. You can drop a tertiary amine into some spots on the steroid framework and immediately come up with no literature hits whatsoever. Many others yield only a handful.
It's worth noting that the partially-aromatized steroids have had some of this kind of work done on them - for example here and here. The aromatic rings give you a bit more of a handle to work with, but even here it's not like the literature is always packed with examples.
So there's as bioactive a scaffold as you could ask for, but many of the simple analogs still haven't been described. To be fair, these azasteroids aren't simple to make, and probably wouldn't have steroid-like activities in many cases. (Their natural receptors sure aren't expecting a basic amine in those spots). But many azasteroids do show biological activities, and I'd be quite surprised if these unknown compounds were pharmacologically inert. It's just that there's been no particular reason to make any of them yet. Chemical space is so huge, and our ability to explore it has been with us for such a relatively short time, that we just haven't gotten around to them yet.
+ TrackBacks (0) | Category: The Scientific Literature
POST A COMMENT
- RELATED ENTRIES
- The Last Post
- The GSK Layoffs Continue, By Proxy
- The Move is Nigh
- Another Alzheimer's IPO
- Cutbacks at C&E News
- Sanofi Pays to Get Back Into Oncology
- An Irresponsible Statement About Curing Cancer
- Oliver Sacks on Turning Back to Chemistry